注册 English

Novel synthetic acridine-based derivatives as topoisomerase I inhibitors

Bin Li ,  Chun-Mei Gao ,  Qin-Sheng Sun ,  Lu-Lu Li ,  Chun-Yan Tan ,  Hong-Xia Liu ,  Yu-Yang Jiang

downloadPDF
Citation:  Bin Li, Chun-Mei Gao, Qin-Sheng Sun, Lu-Lu Li, Chun-Yan Tan, Hong-Xia Liu, Yu-Yang Jiang. Novel synthetic acridine-based derivatives as topoisomerase I inhibitors[J]. Chinese Chemical Letters, 2014, 25(7): 1021-1024. doi: 10.1016/j.cclet.2014.03.028 shu

Novel synthetic acridine-based derivatives as topoisomerase I inhibitors

    • 通讯作者: Chun-Mei Gao,
    Yu-Yang Jiang,
  • 基金项目:

    Shenzhen Sci. & Tech. Bureau (No. JCYJ20120831165730905) for the financial supports. (No. JCYJ20120831165730905)

摘要: Novel DNA binding agents against topoisomerases are needed for effective treatment of cancers. A series of new acridine-based derivatives 7a-7d were synthesized and their antiproliferative activity against K562 and HepG-2 cell lines were evaluated. Compound 7c with pyridin-2-yl-methanamino group substituted at the C9 position of acridine showed good antitumor activity against both cell lines. The DNA-binding affinity of compound 7c was evaluated by UV-vis absorption spectra and fluorescence emission spectra. DNA topoisomerase I mediated relaxation of plasmid pBR322 DNA was also tested. Our results suggested that compound 7c with good antitumor activity and topoisomerase I inhibition activity can be developed as a prime candidate for further chemical optimization.

English

  • 

    1. [1] I. Kümler, N. Brünner, J. Stenvang, E. Balslev, D.L. Nielsen, A systematic review on topoisomerase I inhibition in the treatment of metastatic breast cancer, Breast Cancer Res. Treat. 138 (2013) 347-358.[1] I. Kümler, N. Brünner, J. Stenvang, E. Balslev, D.L. Nielsen, A systematic review on topoisomerase I inhibition in the treatment of metastatic breast cancer, Breast Cancer Res. Treat. 138 (2013) 347-358.

    2. [2] X. Zhang, B. Bao, X.H. Yu, et al., The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase, Bioorg. Med. Chem. 21 (2013) 6981-6995.[2] X. Zhang, B. Bao, X.H. Yu, et al., The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase, Bioorg. Med. Chem. 21 (2013) 6981-6995.

    3. [3] S.M.B. Nijman, S.H. Friend, Cancer. Potential of the synthetic lethality principle, Science 342 (2013) 809-811.[3] S.M.B. Nijman, S.H. Friend, Cancer. Potential of the synthetic lethality principle, Science 342 (2013) 809-811.

    4. [4] Y. Li, H.B. Zhang, W.L. Huang, X. Zhen, Y.M. Li, Synthesis and biological evaluation of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer, Chin. Chem. Lett. 19 (2008) 169-171.[4] Y. Li, H.B. Zhang, W.L. Huang, X. Zhen, Y.M. Li, Synthesis and biological evaluation of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer, Chin. Chem. Lett. 19 (2008) 169-171.

    5. [5] L.H. Shen, Y. Li, D.H. Zhang, Y.S. Lai, L.J. Liu, Synthesis and evaluation of nitrate derivatives of colchicine as anticancer agents, Chin. Chem. Lett. 22 (2011) 768-770.[5] L.H. Shen, Y. Li, D.H. Zhang, Y.S. Lai, L.J. Liu, Synthesis and evaluation of nitrate derivatives of colchicine as anticancer agents, Chin. Chem. Lett. 22 (2011) 768-770.

    6. [6] C. Kaplan-Ozen, B. Tekiner-Gulbas, E. Foto, et al., Benzothiazole derivatives as human DNA topoisomerase II alpha inhibitors, Med. Chem. Res. 22 (2013) 5798-5808.[6] C. Kaplan-Ozen, B. Tekiner-Gulbas, E. Foto, et al., Benzothiazole derivatives as human DNA topoisomerase II alpha inhibitors, Med. Chem. Res. 22 (2013) 5798-5808.

    7. [7] Z.Y. Tian, H.X. Ma, S.Q. Xie, et al., Synthesis, DNA binding and topoisomerase inhibition of mononaphthalimide homospermidine derivatives, Chin. Chem. Lett. 19 (2008) 509-512.[7] Z.Y. Tian, H.X. Ma, S.Q. Xie, et al., Synthesis, DNA binding and topoisomerase inhibition of mononaphthalimide homospermidine derivatives, Chin. Chem. Lett. 19 (2008) 509-512.

    8. [8] J.R. Goodell, A.V. Ougolkov, H. Hiasa, et al., Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis, J. Med. Chem. 51 (2012) 179-182.[8] J.R. Goodell, A.V. Ougolkov, H. Hiasa, et al., Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis, J. Med. Chem. 51 (2012) 179-182.

    9. [9] K. Padget, A. Stewart, P. Charlton, M.J. Tilby, C.A. Austin, An investigation into the formation of N-2-(dimethylamino)ethyl acridine-4-carboxamide (DACA) and 6-2-(dimethylamino)ethylamino-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells, Biochem. Pharmacol. 60 (2000) 817-821.[9] K. Padget, A. Stewart, P. Charlton, M.J. Tilby, C.A. Austin, An investigation into the formation of N-2-(dimethylamino)ethyl acridine-4-carboxamide (DACA) and 6-2-(dimethylamino)ethylamino-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells, Biochem. Pharmacol. 60 (2000) 817-821.

    10. [10] J.Y. Chang, C.F. Lin, W.Y. Pan, et al., New analogues of AHMA as potential antitumor agents: synthesis and biological activity, Bioorg. Med. Chem. 11 (2003) 4959-4969.[10] J.Y. Chang, C.F. Lin, W.Y. Pan, et al., New analogues of AHMA as potential antitumor agents: synthesis and biological activity, Bioorg. Med. Chem. 11 (2003) 4959-4969.

    11. [11] K. Rastogi, J.Y. Chang, W.Y. Pan, et al., Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation, J. Med. Chem. 45 (2002) 4485-4493.[11] K. Rastogi, J.Y. Chang, W.Y. Pan, et al., Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation, J. Med. Chem. 45 (2002) 4485-4493.

    12. [12] R. Zittoun, m-AMSA: a review of clinical data, Eur. J. Cancer Clin. Oncol. 21 (1985) 649-653.[12] R. Zittoun, m-AMSA: a review of clinical data, Eur. J. Cancer Clin. Oncol. 21 (1985) 649-653.

    13. [13] T.L. Su, T.C. Chou, J.Y. Kim, et al., 9-Substituted acridine-derivatives with long halflife and potent antitumor-activity-synthesis and structure-activity-relationships, J. Med. Chem. 38 (1995) 3226-3235.[13] T.L. Su, T.C. Chou, J.Y. Kim, et al., 9-Substituted acridine-derivatives with long halflife and potent antitumor-activity-synthesis and structure-activity-relationships, J. Med. Chem. 38 (1995) 3226-3235.

    14. [14] I. Gonzalez-Sanchez, J.D. Solano, M.A. Loza-Mejia, et al., Antineoplastic activity of the thiazolo 5, 4-b quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation, Eur. J. Med. Chem. 46 (2011) 2102-2108.[14] I. Gonzalez-Sanchez, J.D. Solano, M.A. Loza-Mejia, et al., Antineoplastic activity of the thiazolo 5, 4-b quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation, Eur. J. Med. Chem. 46 (2011) 2102-2108.

    15. [15] C.H. Chen, Y.W. Lin, X.G. Zhang, et al., Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings, Eur. J. Med. Chem. 44 (2009) 3056-3059.[15] C.H. Chen, Y.W. Lin, X.G. Zhang, et al., Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings, Eur. J. Med. Chem. 44 (2009) 3056-3059.

    16. [16] X.D. Luan, C.M. Gao, N.N. Zhang, et al., Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors, Bioorg. Med. Chem. 19 (2011) 3312-3319.[16] X.D. Luan, C.M. Gao, N.N. Zhang, et al., Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors, Bioorg. Med. Chem. 19 (2011) 3312-3319.

    17. [17] Y.Q. Li, C.Y. Tan, C.M. Gao, et al., Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors, Bioorg. Med. Chem. 19 (2011) 4529-4535.[17] Y.Q. Li, C.Y. Tan, C.M. Gao, et al., Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors, Bioorg. Med. Chem. 19 (2011) 4529-4535.

    18. [18] X.L. Lang, L.L. Li, Y.Z. Chen, et al., Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents, Bioorg. Med. Chem. 21 (2013) 4170-4177.[18] X.L. Lang, L.L. Li, Y.Z. Chen, et al., Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents, Bioorg. Med. Chem. 21 (2013) 4170-4177.

    19. [19] X.L. Lang, Q.S. Sun, Y.Z. Chen, et al., Novel synthetic 9-benzyloxyacridine analogue as both tyrosine kinase and topoisomerase I inhibitor, Chin. Chem. Lett. 24 (2013) 677-680.[19] X.L. Lang, Q.S. Sun, Y.Z. Chen, et al., Novel synthetic 9-benzyloxyacridine analogue as both tyrosine kinase and topoisomerase I inhibitor, Chin. Chem. Lett. 24 (2013) 677-680.

    20. [20] C.M. Gao, F. Liu, X.D. Luan, et al., Novel synthetic 2-amino-10-(3, 5-dimethoxy) benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents, Bioorg. Med. Chem. 18 (2010) 7507-7514.[20] C.M. Gao, F. Liu, X.D. Luan, et al., Novel synthetic 2-amino-10-(3, 5-dimethoxy) benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents, Bioorg. Med. Chem. 18 (2010) 7507-7514.

    21. [21] C.M. Gao, S.F. Li, X.L. Lang, et al., Synthesis and evaluation of 10-(3, 5-dimethoxy) benzyl-9(10H)-acridone derivatives as selective telomeric G-quadruplex DNA ligands, Tetrahedron 68 (2012) 7920-7925.[21] C.M. Gao, S.F. Li, X.L. Lang, et al., Synthesis and evaluation of 10-(3, 5-dimethoxy) benzyl-9(10H)-acridone derivatives as selective telomeric G-quadruplex DNA ligands, Tetrahedron 68 (2012) 7920-7925.

    22. [22] X.D. Luan, C.M. Gao, Q.S. Sun, et al., Novel synthetic azaacridine analogues as topoisomerase 1 inhibitors, Chem. Lett. 40 (2011) 728-729.[22] X.D. Luan, C.M. Gao, Q.S. Sun, et al., Novel synthetic azaacridine analogues as topoisomerase 1 inhibitors, Chem. Lett. 40 (2011) 728-729.

    23. [23] X.L. Lang, X.D. Luan, C.M. Gao, Y.Y. Jiang, Recent progress of acridine derivatives with antitumor activity, Prog. Chem. 24 (2012) 1497-1505.[23] X.L. Lang, X.D. Luan, C.M. Gao, Y.Y. Jiang, Recent progress of acridine derivatives with antitumor activity, Prog. Chem. 24 (2012) 1497-1505.

  • 加载中
WeChat 扫一扫看文章
计量
  • PDF下载量:  0
  • 文章访问数:  1369
  • HTML全文浏览量:  25
文章相关
  • 收稿日期:  2013-12-25
  • 网络出版日期:  2014-03-05
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章

All Rights Reserved by the Chinese Chemical Society   中国化学会 版权所有 京ICP备05002797号

本系统由北京仁和汇智信息技术有限公司开发    技术支持: info@rhhz.net